Kaiser Permanente Southern California Department of Research & Evaluation has developed a COVID-19 risk assessment factoring in a number of patient variables enabling a critical poor outcome without the need for any laboratory or diagnostic testing as reported in a recent press release by the California-headquartered health system. With the results of a retrospective study involving 26,600 emergency department patients suspected of COVID-19 infection, the study team recently had their results published in the peer-reviewed American Journal of Emergency Medicine. The Kaiser Permanente Southern California-developed assessment tool helps emergency department physicians better ensure patients get the right care, when they need it, by accurately predicting the probability that patients with COVID-19 symptoms will experience severe disease or even death. The tool produces a risk score which can be of particular value for physicians that need to make swift decisions at the point of emergency department care reports Adam Sharp, MD, emergency medicine physician and researcher.
Introduction to COVAS Score
Kaiser Permanente recently introduce the COVAS score as an assessment tool ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).